Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.
about
Non-alcoholic fatty liver disease: what the clinician needs to know.Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trialsA Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDRelevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver DiseaseEndocrine causes of nonalcoholic fatty liver diseaseNonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment StrategyAssociation of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-AnalysisExercise for hepatic fat accumulation in type 2 diabetic subjectsReview of nonalcoholic fatty liver disease in women with polycystic ovary syndromeLessons from mouse models of high-fat diet-induced NAFLDDietary habits and behaviors associated with nonalcoholic fatty liver diseaseNon-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatmentTreatment of nonalcoholic steatohepatitis in adults: present and futureRole of diet on non-alcoholic fatty liver disease: An updated narrative reviewMultiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)Psychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver diseaseCardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature reviewMetformin and metabolic diseases: a focus on hepatic aspectsThe Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in MiceOmic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease.Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis.Nonalcoholic Steatohepatitis and Endpoints in Clinical Trials.Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy.Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.Modification of a simple clinical scoring system as a diagnostic screening tool for non-alcoholic steatohepatitis in Japanese patients with non-alcoholic fatty liver disease.Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysisNonalcoholic fatty liver disease and the heart in children and adolescents.Liver enzymes and psychological well-being response to aerobic exercise training in patients with chronic hepatitis C.Nonalcoholic fatty liver disease and aging: epidemiology to management.Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials.Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective.Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease.Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin.Revisiting PPARγ as a target for the treatment of metabolic disordersEffects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
P2860
Q24563068-A8D1D785-87CA-45E0-AAF4-0954AEA48BD3Q26748608-739F96C7-F7F0-4FD9-BCC8-ABCA9C2EE11CQ26752487-357341F0-5521-40BE-9D18-B5766007B833Q26778020-DC2741F6-EABF-425F-9BC2-C2BA4273FE78Q26780254-C5739F50-D356-4439-9DC4-19A8F4552141Q26781753-2C339A05-9472-43E4-A891-877144C10CECQ26798155-0827289D-8827-404A-8B8D-CEA25187D143Q26827764-22140615-34AD-42A3-8E8C-8C1A7A82CCA0Q26828765-8455FC6E-5AFB-4891-BF97-BFF63BCE5CA7Q26829532-0C4ECB82-6B4B-4581-B6DA-423EFF13CACEQ26830594-580DFB02-B5C0-4D1A-AD19-590F618DA473Q26852019-95E570CC-9B13-4912-84FF-7527215D37C0Q26852403-3D311E0C-E11E-4CC9-BA4D-961A8EF3E5D7Q27000333-8E7EF6D1-5377-4B1E-97E9-14B68E1E309BQ27007515-3E921F6F-C529-4E81-9778-F6476810EB9DQ27012600-756D7D0D-FF43-4209-8AEE-584A0D5B210BQ28081066-B46F9E3D-310E-40D9-B36F-F92E8B98F8EEQ28082736-05D682D8-4468-4248-903B-DADD7070C9CBQ28552063-C50D2CA2-FCFE-4A3A-9CAB-3047D72C80CDQ30244335-B0B4F26C-4FB9-4AF8-862C-15A75C8A1362Q30248535-5FDE0F88-B424-49DB-B396-9C5CCF61E504Q30396916-C3A0752C-4853-4AB8-965B-81BF2DC03498Q30441653-54C64E4F-57DE-4FAF-B7C5-DF097890A5B7Q33579420-12F09313-4E83-495A-8543-C4E4387AD0F4Q33607793-4FFD4B2E-DE99-4381-BDEA-E12797F1D1A4Q33652021-09AC5038-05DF-4506-B5BB-6AAB965107EFQ33724815-470005CB-3302-4853-B831-97E02ADD2D8BQ33755566-7913B1EB-3005-49E9-A3D3-58AD8772B840Q33932951-A2600575-DB4E-429D-B48D-ABE74A2614F8Q33958722-61D29EB6-771C-4F0C-8718-EB10F0208A60Q34335564-78B53A20-D133-4FC5-A2B2-3B46FD767BEBQ34366861-92A8817F-14A9-43D9-85D0-1ACD005D0C5EQ34406791-68099E31-8572-48EE-BED7-7A1D8D05AB7DQ34412650-D611D304-17B3-474C-AC00-7C5F102C4FC5Q34419171-17F9A19B-A2F8-4C31-9AB8-C6B33D66EA42Q34647390-A43C685F-07A9-4A2B-B3DC-994A7289483BQ34647400-0B21F55A-2102-46F4-BD9C-3E64B3E6E51EQ34657137-00897D89-A8F7-4F8C-8C50-A3283325D265Q34798213-331553BB-5BE3-4CB6-9895-05F73C2ADD30Q35031260-95B56A55-201E-4EF4-90AE-448441DA94EA
P2860
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Impact of current treatments o ...... analysis of randomised trials.
@en
Impact of current treatments o ...... analysis of randomised trials.
@nl
type
label
Impact of current treatments o ...... analysis of randomised trials.
@en
Impact of current treatments o ...... analysis of randomised trials.
@nl
prefLabel
Impact of current treatments o ...... analysis of randomised trials.
@en
Impact of current treatments o ...... analysis of randomised trials.
@nl
P2093
P2860
P921
P1433
P1476
Impact of current treatments o ...... analysis of randomised trials.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00125-011-2446-4
P577
2012-01-27T00:00:00Z